Lates News

Every Economy AI Express, Huaxia Securities released a research report on August 28th, giving Kailaiying (002821.SZ) a buy rating. The rating reasons mainly include: 1) Rich reserves of small molecule commercialization orders, further improvement in gross profit margin; 2) Rapid development of large molecule business, formulation, clinical CRO and other businesses continue to recover; 3) Accelerated global market expansion, steady progress in overseas production capacity construction. (Daily Economic News)